Role of cytokines in the modulation of nitric oxide production by cyclic AMP

European Cytokine Network

Volumn 12, Issue 1, 2001, Pages 22-32

  Zidek Z ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

Cyclic AMP; Interferon ; Interleukin 10; Nitric oxide; Prostaglandins; Tumor necrosis factor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLERA TOXIN; CYCLIC AMP; CYTOKINE; FORSKOLIN; GAMMA INTERFERON; INTERLEUKIN 10; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; FEEDBACK SYSTEM; HUMAN; IMMUNE SYSTEM; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ADENOSINE; ANIMALS; CYCLIC AMP; CYTOKINES; NITRIC OXIDE;

EID: 0035071004     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (180)

1. The role of cAMP regulation in controlling inflammation
2. Adenosine: Some therapeutic applications and prospects
3. Nitric oxide-based possibilities for pharmacotherapy
4. Adenosine kinase inhibitors
5. Adenosine receptors: New opportunities for future drugs
6. Adenosine triphosphate: Established and potential clinical applications
7. Nitric oxide: Discovery and impact on clinical medicine
8. Induction of nitric oxide synthase in cultured smooth muscle cells: The role of cyclic AMP
9. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes
10. Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes
11. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxide
12. An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-γ-treated macrophages
13. Differential regulation of nitric oxide production by increase of intracellular cAMP in murine primary fibroblasts and L929 fibrosarcoma cell line
14. Pyrrolidine dithiocarbamate differentially affects interleukin-lβ- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells
15. Cyclic AMP-elevating agents induce an inducible type nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines
16. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells
17. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP
18. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells
19. cAMP analogues and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures
20. Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signaling mechanism
21. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-ΚB
22. +-ATPase activity in SH-SY 5Y human neuroblastoma cells
23. Potentiation of cytokine induced iNOS expression in the human intestinal epithelial cell line, DLD- 1, by cyclic AMP
24. Dipyridamole enhances interleukinlbeta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells
25. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells
26. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: Regulation by cyclic nucleotides
27. Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells
28. 2-adrenoceptors in human umbilical vein endothelium in vitro
29. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes
30. Regulation of nitric oxide production by stimulated rat Kupffer cells
31. 2 and of agents that raise cAMP levels on macrophage activation induced by IFN-γ and TNF-α
32. Increasing cAMP attenuates induction of inducible nitricoxide synthase in rat primary astrocytes
33. LPS-induced activation of primed murine peritoneal macrophages is modulated by prostaglandins and cyclic nucleotides
34. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures
35. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP
36. 2
37. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression. Naunyn-Schmiedeberg's Arch
38. 2α and nitric oxide
39. 2α via adenylate cyclase and phospholipase C
40. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages
41. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cylic AMP-dependent signal transduction pathway
42. 2 negatively modulates induction of nitric oxide synthase by interleukin- 1
43. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774
44. 2
45. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites
46. Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages
47. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control
48. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ
49. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production
50. Parallel induction of nitric oxide and tetrahydrobiopterin synthesis by cytokines in rat glial cells
51. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
52. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes
53. Effects of interferon-gamma on nitric oxide synthase activity and endothelin- 1 production by vascular endothelial cells
54. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages
55. Cyclic nucleotide regulation of interleukin-lbeta induced nitric oxide synthase expression in vascular smooth muscle cells
56. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide
57. Colitis and interleukin-1β up-regulate inducible nitric oxide synthase and superoxide dismutase in rat myenteric neurons
58. Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-γ
59. A central role for IL-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1β induces hepatic nitric oxide synthesis
60. Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-γ production
61. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans
62. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Thl cell activity via the modulation of the induction of nitric oxide synthase in macrophages
63. IL-4 stimulates cGMP production by 1FN-γ-activated human monocytes. Involvement of the Larginine pathway
64. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages
65. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor a required as a costimulatory factor for interferon-γ-induced activation
66. Induction of macrophage nitric oxide production by interfeton-γ and tumor necrosis factor-α is enhanced by interleukin- 10
67. Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-γ, TGF-β, and IL- 10 in murine macrophage cell lines and rat peritoneal macrophages
68. IFN-αβ reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase
69. Exogenous and endogenous type I interferons inhibit interferon-γ-induced nitric oxide production and nitric synthase expression in murine peritoneal macrophages
70. Increased mortality, blunted production of nitric oxide, and increased production of tumor necrosis factor-α in endotoxemic transforming growth factor-β 1 transgenic mice
71. IL-10 synergises with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity
72. Transforming growth factor-β 1 regulation of macrophage activation depends on the triggering stimulus
73. Inhibition of inducible nitric oxide synthase gene expression and nitric oxide synthesis in vascular smooth muscle cells by granulocyte-colony stimulating factor in vitro
74. Modulation of murine macrophage function by IL- 13
75. Impaired IL- 13 mediated function of macrophages in STAT6 deficient mice
76. Adenosine-cyclic AMP pathways and cytokine expression
77. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor β1- and β2-chain expression
78. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
79. Role of transcription factor NF-ΚB/Rel in induction of nitric oxide synthase
80. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-ΚB-signaling pathways
81. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein-1 and nuclear factor-ΚB-binding sites
82. The effects of interferon-gamma and bacterial lipopolysaccharide on CD 14 expression in human monocytes
83. Neuronal (type I) nitric oxide synthase regulates nuclear factor-kappaB activity and immunologic (type II) nitric oxide synthase expression
84. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds
85. NF-ΚB and AP- 1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages
86. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
87. Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)-mediated neuronal cell death
88. Nitric oxide inhibits apoptosis via AP-l-dependent CD 95L transactivation
89. Amplification of calcium-induced gene transcription by nitricoxide in neuronal cells
90. Nitric oxide and cGMP analogs activate transcription from AP-l-responsive promoters in mammalian cells
91. Amplification of nitric oxide synthase expression by nitric oxide in interleukin-1β-stimulated mesangial cells
92. Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells
93. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages
94. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages
95. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
96. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
97. Increased nitric oxide synthesis during the development of endotoxin tolerance
98. -) regulatory pathways
99. 2 biosynthesis in macrophages
100. * and agonist challenge involves transcriptional regulation mediated by AP- 1 activation
101. Inducible isoform of cyclooxygenase and nitric-oxide synthase in inflammation
102. 2 production by nitric oxide in activated murine macrophages
103. Inhibition of prostacyclin release from cultured endothelial cells by nitrovasodilator drugs
104. Adenylyl cyclase, a coincidence detector for nitric oxide
105. Nitric oxide selectively inhibits adenyly cyclase isoform 5 and 6
106. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide
107. 1
108. Cyclic AMP mediates endothelial protection by nitric oxide
109. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes
110. Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NO
111. An essential role for free radicals and derived species in signal transduction
112. Nitric oxide and thiol redox regulation of Janus kinase activity
113. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages
114. A Spl site of the tumor necrosis factor-α promoter functions as a nitric oxide response element
115. Regulation of transforming growth factor-βl by nitric oxide
116. Interactions between cytokines and nitric oxide
117. Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages
118. Interleukin- 1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide
119. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin- 6 by rat Kupffer cells
120. Up-regulation of interleukin-lβ-stimulated interleukin-8 in human keratinocytes by nitric oxide
121. Nitric oxide-mediated modulation of interleukin-8 production by a human glioblastoma cell line, T 98G, cocultured with myleoid and monocytic cell lines
122. Interleukin-12 gene-expression of macrophages is regulated by nitric oxide
123. Effects of nitric oxide on the induction and differentiation of Th1 cells
124. Mechanisms of cytokine induced bone resorption: Role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins
125. 2 in human lung fibroblast interleukin- 11 production
126. Human tumour necrosis factor-alpha (TNF-α) directly stimulates arachidonic acid release in human neutrophils
127. Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL- 1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages
128. 2 production in resting macrophages
129. Interleukin-1 stimulation of arachidonic acid release from human synovial fibroblasts; blockade by inhibitors of protein kinases and protein synthesis
130. The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines
131. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase- 2 expression
132. Interferon inhibits prostaglandin biosynthesis in macrophages: Effects on arachidonic acid metabolism
133. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ
134. Studies on induction of cyclooxygenase isozymes by various prostaglandins in mouse osteoblastic cell line with reference to signal transduction pathway
135. Differential regulation of cyclooxygenase isozymes by cAMP-elevating agents
136. Adenosine, a potent natural suppressor of arachidonic acid release and leukotriene biosynthesis in human neutrophils
137. Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL- 10 independent
138. Effects of adenosine receptor agonists on nitric oxide release in mouse during endotoxemia
139. Adenosine and its receptor agonists potentiate nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages
140. 2α receptors increase arterial endothelial cell nitric oxide
141. Vasoactive intestinal peptide inhibits IL-I2 and nitric oxide production in murine macrophages
142. Vasoactive intestinal peptide and pitusilary adenylate cyclase-activating polypeptside prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-ΚB and interferon regulatory factor-1 activation
143. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: Primary role of a β-adrenergic receptor/cyclic AMP mechanism
144. Norepinephrine-induced phosphorylation of the transcription factor CREB in isolatd rat pinealocytes: An immunocytochemical study
145. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to translocate to the nucleus and induce c-fos transcription
146. Molecular mechanisms of inducible nitric oxide synthase gene expression by IL-1β and cAMP in rat mesangial cells
147. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: Role of NF-ΚB, CREB and C/EBPβ
148. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP
149. Regulation of lipopolysaccharide-induced NO synthase expression in the major organs in a mouse model. The roles of endogenous interferon-γ, tumor necrosis factor-α and interleukin-10
150. Structure, mechanism, and regulation of mammalian adenylyl cyclase
151. Cyclic nucleotide phosphodiesterases (PDEs): Diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents
152. COX-l, COX-2, and COX- 3 and the future treatment of chronic inflammatory disease
153. A new view of prostaglandin E regulation of the immune response
154. 2 mediates inhibition of insulin secretion by interleukin-lβ
155. 3 receptors on macrophages inhibits tumor necrosis factor-α
156. IL-10: A novel cytotoxic T cell differentiation factor
157. IL-10 enhances expression of the IL-2 receptor α-chain on T cells
158. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin- 4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
159. Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
160. IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFN-γ
161. Interleukin- 10 and immune restoration in common variable immunodeficiency
162. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines
163. Effect of interleukin-10 on NF-ΚB and AP-1 activities in interleukin-2 dependent CD8 T lymphoblasts
164. Role of interferon regulatory factor- 1 in induction of nitric oxide synthase
165. Macrophage deactivation by interleukin- 10
166. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages
167. Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages
168. Opposing effects of interleukin- 10 on mouse macrophage functions
169. Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells
170. Differential effects of pentoxyfylline and interleukin- 10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages
171. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide
172. IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: Improved control of Trypanosoma cruzi infection
173. Interleukin-10 in combination with interferon-γ and tumor necrosis factor-α enhances in vitro production of nitric oxide by murine resident peritoneal macrophage
174. Differential regulation of IL-6, IL-1A, IL-lbeta and TNF-alpha production in LPS-stimulated human monocytes: Role of cyclic AMP
175. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells
176. Characterization of cAMP-dependent inhibition of LPS-induced TNF-α production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor
177. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury
178. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages
179. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: Protection is independent of IL-10-inducing activity
180. + Thl cells pro-inflammatory or anti-inflammatory? The ratio of IL-10 to 1FN-gamma or IL- 2 determines their function